Discovery & Development

A cell-free biologic could act as platform therapeutic for a variety of serious diseases.

What needs to change to improve our odds in the fight against AMR?

Researchers seek a way to inactivate CAR-T cells in case of adverse effects.

We announce a new Special Series of articles devoted to advanced medicine.

What type of dosage form would a patient prefer to take? Additive manufacturing provides the ultimate flexibility.

Why virtual and augmented reality technologies are the future of workforce training.

What’s on the horizon for the field of nanomedicine?

Jeroen den Hertog from the Hubrecht Institute is exploring the bioactive properties of fungal strains.

A novel small molecule aims to tackle both Alzheimer’s disease and Dravet syndrome.

Dale Thomas, Co-founder of Mytide, explains how AI can be used for the discovery and development of peptide therapeutics.